After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Nektar Therapeutics is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Nektar Therapeutics is $165.42M. A total of 2.53 million shares were traded on the day, compared to an average of 2.01M shares.
In the most recent transaction, Zalevsky Jonathan sold 10,300 shares of NKTR for 1.01 per share on Feb 19 ’25. After the transaction, the Chief R&D Officer now owns 316,604 company shares. In a previous transaction on Feb 19 ’25, Wilson Mark Andrew sold 11,040 shares at 1.01 per share. NKTR shares that Chief Legal Officer owns now total 324,292.
Among the insiders who sold shares, ROBIN HOWARD W disposed of 23,774 shares on Feb 19 ’25 at a per-share price of $1.01. This resulted in the President & CEO holding 1,086,901 shares of NKTR after the transaction. In another insider transaction, Wilson Mark Andrew bought 11,040 shares at $1.01 per share on Feb 19 ’25.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, NKTR has a high of $1.93 and a low of $0.65.
As of this writing, NKTR has an earnings estimate of -$0.18 per share for the current quarter. EPS was calculated based on a consensus of 2.0 estimates, with a high estimate of -$0.16 per share and a lower estimate of -$0.19.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. NKTR’s latest balance sheet shows that the firm has $733.96M in Cash & Short Term Investments as of fiscal 2021. There were $143.18M in debt and $85.20M in liabilities at the time. Its Book Value Per Share was $0.27, while its Total Shareholder’s Equity was $679.51M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for NKTR is Buy with a score of 4.11.
